Archer Investment Corp Abb Vie Inc. Transaction History

Archer Investment Corp

$373 Billion
Q3 2024

A detailed history of Archer Investment Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Archer Investment Corp holds 7,913 shares of ABBV stock, worth $1.39 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

7,913

Previous 7,934 0.26%

Holding current value

$1.39 Million

Previous $1.36 Billion 14.83%

% of portfolio

0.42%

Previous 0.4%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$163.84 - $199.33 $3,440 - $4,185	-21 Reduced 0.26%	7,913 $1.56 Billion
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $63,618 - $74,292	411 Added 5.46%	7,934 $1.36 Billion
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $22,214 - $25,311	-139 Reduced 1.81%	7,523 $1.37 Billion
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $1,788 - $2,014	13 Added 0.17%	7,662 $1.19 Billion
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $1,469 - $1,701	11 Added 0.14%	7,649 $1.14 Billion
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $226,592 - $281,979	-1,710 Reduced 18.29%	7,638 $1.03 Billion
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $58,711 - $67,615	406 Added 4.54%	9,348 $1.41 Billion
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $4,010 - $4,810	29 Added 0.33%	8,942 $1.45 Billion
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $1,476 - $1,693	11 Added 0.12%	8,913 $1.2 Billion
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $4,128 - $5,248	30 Added 0.34%	8,902 $1.36 Billion
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $11,746 - $14,573	-89 Reduced 0.99%	8,872 $1.45 Billion
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $9,776 - $12,369	91 Added 1.03%	8,961 $1.21 Billion
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $5,426 - $6,159	51 Added 0.58%	8,870 $957 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $526 - $586	5 Added 0.06%	8,819 $993 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $20,766 - $28,036	-258 Reduced 2.84%	8,814 $944 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $12,285 - $14,418	-143 Reduced 1.55%	9,072 $795 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $7,923 - $10,603	108 Added 1.19%	9,215 $904,000
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $122,098 - $185,116	1,893 Added 26.24%	9,107 $694,000
Q4 2019 Feb 20, 2020	BUY	$72.13 - $90.25 $91,605 - $114,617	1,270 Added 21.37%	7,214 $638,000
Q3 2019 Apr 01, 2020	SELL	$62.98 - $75.72 $38.9 Million - $46.7 Million	-617,262 Reduced 99.05%	5,944 $450,000
Q2 2019 May 19, 2020	BUY	$65.7 - $83.98 $40.3 Million - $51.5 Million	613,162 Added 6104.76%	623,206 $450,000
Q1 2019 Apr 09, 2020	BUY	$77.14 - $90.79 $43,198 - $50,842	560 Added 5.9%	10,044 $820,000
Q4 2018 Apr 06, 2020	BUY	$77.85 - $96.01 $738,329 - $910,558	9,484 New	9,484 $874,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.

Account

Archer Investment Corp Abb Vie Inc. Transaction History